Ypsomed Holding AG Company Description
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies.
The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices.
This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics.
This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services.
It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors.
It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
![Ypsomed Holding AG logo](https://img.stockanalysis.com/logos1/SW/YPSN.png)
Country | Switzerland |
Founded | 1984 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 2,296 |
CEO | Simon Michel |
Contact Details
Address: Brunnmattstrasse 6 Burgdorf, 3401 Switzerland | |
Phone | 41 34 424 41 11 |
Website | ypsomed.com |
Stock Details
Ticker Symbol | YPSN |
Exchange | SIX Swiss Exchange |
Fiscal Year | January - December |
Reporting Currency | CHF |
ISIN Number | CH0019396990 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Simon Michel | Chief Executive Officer and Member of the Board |
Samuel Kunzli | Chief Financial Officer |
Frank Mengis | Chief Operating Officer |
Thomas Kutt | Head of Investor Relations |
Dr. Nicolas Meyer | Chief Legal Officer and Secretary |
Michael Zaugg | Chief Corporate Officer |
Ulrike Bauer | Chief Business Officer of Ypsomed Delivery Systems |
Sebastien Delarive | Chief Business Officer of Ypsomed Diabetes Care |